Products

Clinopodii Herba Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    • Product Name: Clinopodii Herba Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    • Alias: Clinopodii Herba Vet
    • Einecs: 931-334-4
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    769906

    Product Name Clinopodii Herba Veterinary Grade API
    Appearance Light brown to brownish powder
    Purity ≥98%
    Part Used Aerial parts of Clinopodium chinense
    Intended Use Veterinary pharmaceuticals
    Dosage Forms Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions
    Main Active Ingredients Flavonoids, phenolic acids, volatile oils
    Storage Conditions Store in a cool, dry, and well-ventilated place
    Shelf Life 24 months
    Solubility Partially soluble in water
    Country Of Origin China
    Standard Complies with Veterinary Pharmacopoeia requirements

    As an accredited Clinopodii Herba Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Sealed 25kg fiber drum with double-layer polyethylene bag liner, labeled "Clinopodii Herba Veterinary API," suitable for tablets/injections/capsules/powder/granules/premix/solutions.
    Shipping Clinopodii Herba Veterinary Grade API is securely packaged in sealed, moisture-resistant, and tamper-proof containers, ensuring product integrity during transit. Shipped via reputable freight carriers at ambient or specified conditions, the shipment includes clear labeling and documentation for regulatory compliance and traceability. Custom packaging options and expedited shipping are available upon request.
    Storage Clinopodii Herba Veterinary Grade API should be stored in a cool, dry, and well-ventilated area, away from direct sunlight, moisture, and incompatible substances. Keep tightly sealed in original containers. Store at temperatures below 25°C. Ensure containers are labeled and protected from physical damage. Follow standard storage guidelines for APIs intended for use in tablets, injections, capsules, powders, granules, premixes, and solutions.
    Application of Clinopodii Herba Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    Applications of Clinopodii Herba Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions in Industrial Manufacturing

    As a direct manufacturer of veterinary-grade Clinopodii Herba API, we supply raw materials to leading animal health product producers strictly for regulated downstream uses. Below, we outline established application scenarios across legalized animal drug and nutritional supplement sectors, focusing on each industry’s compliance requirements, formulation ratios, integration into plant-level workflows, and the resulting market-ready products.

    1. Veterinary Tablet Formulations for Companion Animals

    Major pharmaceutical companies utilize our Clinopodii Herba API for the formulation of veterinary oral tablets targeting inflammatory disorders in companion animals, especially dogs and cats. The extract is incorporated for its approved phyto-compound profile within legal monograph limits, supported by detailed material traceability and residue control. Final formulations address pet-specific dosing standards while ensuring stringent batch-to-batch consistency.

    Industry compliance standards

    • European Pharmacopeia Monograph (Ph. Eur) for Herbal Veterinary Medicines
    • Veterinary Drugs Good Manufacturing Practice (GMP) as per EMA and FDA-CVM
    • China Veterinary Pharmacopoeia (2020 Edition)
    • EU Regulation 2019/6 on Veterinary Medicinal Products

    Typical usage ratio

    • Standard inclusion range: 2%–6% w/w in dry blend, adjusted by animal weight class and tablet size for species-specific dose titration.

    Downstream process integration

    • API introduced during the direct compression step, followed by blending with excipients, wet granulation (if modified release is required), and tableting under controlled humidity.

    Final product types

    • Chewable veterinary tablets for oral administration
    • Immediate-release and modified-release scored tablets
    • Dose-tiered tablets for various breed sizes

    2. Parenteral Injectable Preparations for Livestock Disease Management

    Livestock pharmaceutical producers include Clinopodii Herba API in injectable solutions used for managing respiratory or urinary tract disorders in swine and bovines. Compliance-driven sourcing, sterile processing, and full residue documentation underpin product acceptance in regulated markets. The extract’s composition supports defined therapeutic roles with fixed-label dosing for major livestock species.

    Industry compliance standards

    • OIE Terrestrial Animal Health Code substance controls
    • US FDA 21 CFR Part 514 (New Animal Drug Applications)
    • China Veterinary Drug GMP (2019 Revision)
    • ISO 22716:2007 (Cosmetics - GMP) for veterinary injectables where required

    Typical usage ratio

    • 0.5%–1.5% w/v; concentration selected based on label claim, animal species, and supportive toxicology data.

    Downstream process integration

    • API added to aqueous carrier after pH adjustment, sterile filtration, and filling into vials or ampoules under aseptic conditions prior to terminal sterilization.

    Final product types

    • Ready-to-inject solutions for cattle, swine, and sheep
    • Single- and multidose veterinary injectable ampoules
    • Sterile suspensions for IM or IV administration

    3. Premix Additives for Poultry and Swine Feed

    Feed additive manufacturers rely on our raw Clinopodii Herba API for formulation of herbal premixes, deployed as standardized nutraceuticals in commercial poultry and swine operations. Regulatory transparency is maintained by providing full batch analysis and residual solvent reports, ensuring product eligibility in global trading channels while supporting precise feed conversion targets.

    Industry compliance standards

    • European Feed Additives Regulation (EC) No 1831/2003
    • AAFCO Official Publication guidelines (USA)
    • China Feed Hygiene Regulation (GB13078-2017)
    • ISO 22000:2018 Food Safety Management Systems for feed plants

    Typical usage ratio

    • Typically blended at 0.01%–0.05% w/w, finely adjusted according to target animal species, projected feed intake, and desired herbal load per kg feed.

    Downstream process integration

    • API incorporated during premix batch blending before addition to main feed, followed by further homogenization in feed mill mixers and downstream conditioning/pelleting.

    Final product types

    • Certified veterinary premix powders for on-farm dosing
    • Compound feed blends for poultry and swine
    • Vitamin-herbal granulate premixes

    4. Veterinary Oral Powder Formulations for Aquaculture

    Fish health enterprises integrate our Clinopodii Herba API into oral powder blends, specifically indicated as feed-grade supplements for high-value fish species such as tilapia and carp. Material compliance targets food residue safety for aquaculture exports, and QA protocols ensure trace phytochemical markers per aquatic pharmacopoeia listing.

    Industry compliance standards

    • FAO/WHO Codex Alimentarius - Veterinary Drug Residues
    • EEC No 2377/90 for Maximum Residue Limits in food-producing species
    • China MOA Veterinary Drug Residue Standards (GB/T 29686-2013)
    • Local aquatic animal drug registration dossiers

    Typical usage ratio

    • Recommended range: 0.05%–0.2% w/w of total daily feed ration, modulated as per fish biomass and environmental factors.

    Downstream process integration

    • Mixed into vitamin-mineral powder bases pre-packaging; optionally post-pelleting for heat-sensitive preservation.

    Final product types

    • Aquatic veterinary oral powders for direct feed top-coating
    • Bags and sachets for on-site farm admixture
    • Nutritional fish feed supplements

    5. Veterinary Capsule Blends for Exotic and Small Mammal Species

    Specialty animal health brands use our material in hard gelatine capsule blends prioritized for rabbits, guinea pigs, and certain zoo animals. Product formulation considers encapsulation stability, compatibility with common veterinary excipients, and labeling requirements for unconventional animal targets, underpinned by reliable API identification and allergen screening reports.

    Industry compliance standards

    • British Veterinary Pharmacopoeia requirements
    • Global Veterinary Drug GMP guidelines (VICH GL9, VICH GL42)
    • USP-NF Herbal Medicines Chapter where applicable
    • Regional veterinary labeling regulations

    Typical usage ratio

    • Loading between 1%–4% per capsule filler blend, finalized after review of species-specific studies and clinical reference sources.

    Downstream process integration

    • Bulk powder introduced to the mixer, encapsulation run on semi-automatic capsule filling lines, with in-process sampling for weight/precision.

    Final product types

    • Veterinary capsules for specialty small mammal clinics
    • Unit-dose packages for zoo and exotic pet pharmacy
    • Blister-packed herbal veterinary capsules

    6. Granulated Veterinary Blends for Large-Scale Bovine Operations

    Major ruminant health product manufacturers standardize our API as a blended granular input for herd-scale dosing. Formulation processes and sustainability audits verify particle-size control and content uniformity to support the high-throughput granulation lines typical of intensive dairy and beef production facilities, matching traceability with delivery speed.

    Industry compliance standards

    • ISO 9001:2015 certified quality processes
    • Regulation (EU) 2019/4 on Medicated Feed
    • GMP+ Feed Safety Assurance protocol
    • Veterinary Drug Supply Chain Traceability as per IRVEP standards

    Typical usage ratio

    • Applied at 0.1%–0.3% per granulated premix batch, varied based on herd size, desired duration, and seasonal health program.

    Downstream process integration

    • API dry-mixed prior to extrusion and granulation, with final screening and sifting ahead of packaging under controlled temperature/humidity.

    Final product types

    • Bulk granulated additives for ruminant veterinary application
    • Medicated mineral granules for on-farm dosing systems
    • Bagged herbal granulate products for distribution to feedlots

    Free Quote

    Competitive Clinopodii Herba Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Clinopodii Herba Veterinary Grade API: Supporting Efficient Animal Health Solutions

    Understanding Clinopodii Herba as a Raw Material

    Based on our practical manufacturing experience, the value of Clinopodii Herba Veterinary Grade API stems from careful handling, consistent processing, and strict quality controls at every step. Raw Clinopodii Herba demands gentle yet thorough cleaning, precise drying, and a clean milling environment; these safeguard both complex actives and natural micronutrients found in the plant. Deviation from detailed care here carries the risk of contamination or uncontrolled loss of key bioactive compounds. Our teams have spent years refining incoming herb selection, using deep color, aroma, and specific absorbance as immediate onsite tests before any batch release. The sense of responsibility goes beyond regulation; for every vet-administered batch, the health of an animal depends on unseen rigor along every meter of the line.

    Granulation and Particle Sizing: The Influence on Formulation Choices

    The effectiveness of Clinopodii Herba in dosage forms such as tablets, powders, granules, and capsules starts with the right particle profile. Granule size can impact dissolution and, by extension, absorbability. Too coarse, and bioactives extract poorly. Too fine, and the dust introduces manufacturing hazards and loss rates skyrocket during weighing and transfer. Our operation uses closed-loop sizing, with rotary sieves monitored continuously, and routine random checks by senior staff during production. These steps ensure that for premixes, powders, or blends used in tablets, the consistency supports predictable performance every time, down to the last kilogram.

    Formulation scientists, especially those focused on poultry or swine feed applications, often call attention to the difference between untreated herbal powder and pure API extracts. Untreated herb powder, sometimes seen in local markets, brings wide variability. Customers often find batch-to-batch differences in aroma and effectiveness. Our process extracts targeted fractions, then returns precise concentration—removing most non-essential plant fiber. This concentrated approach controls both dosing and storage, reducing waste and improving end-product shelf life, important for international partners managing expansive logistics chains.

    Tablet, Capsule, and Injection Use: Practical Application Insights

    Clinopodii Herba, when offered as a veterinary API, sees most application in oral dosage—tablets and capsules—but also serves well in solution or powder forms for granulated feed. Our experience in pilot manufacturing revealed that extracting appropriate fractions is essential for injectables. Solubility hurdles demand fine, even processing. Full dissolution is crucial for injection stability, so we tax every resource from pharmacopeial solvent selection to multi-stage filtration. This attention to detail keeps sediment out of finished vials. For oral solutions, rapid re-dispersibility and clarity are vital, preventing clumping or “settle-out” in suspension forms.

    Tableting demands a different focus. Organic plant APIs bring coprocessing challenges, especially when binders and anti-caking agents interact with native plant polysaccharides. Through iterative trials, our formulation chemists identified binder grades that work with Clinopodii Herba to ensure hard, stable tablets without “capping” (where tablets split during compression). Similar lessons emerged for capsule filling, where low bulk density once led to dose variability. Tighter particle distribution and precise control of residual moisture, introduced via gentle vacuum drying, produced better flow and consistent capsule weights across automatic filling runs.

    Antimicrobial Activity and Its Place in Modern Veterinary Practice

    Veterinary professionals seek safe, reliable plant-derived options as concern grows over conventional antibiotic overuse. Clinopodii Herba APIs carry a long tradition in Eastern animal husbandry, recognized for their support in respiratory, urinary, and digestive tract health. Through partner collaborations and published trials, we notice the greatest benefit in complex cases where resistance to standard antibiotics exists. The main compounds—flavonoids, glycosides, and saponins—stand out in laboratory bioassays for broad antimicrobial action. In our facilities, every batch undergoes both identity confirmation and full-range impurity profiling, something that distinguishes manufacturer-driven supply from trader intermediaries.

    Reports from field veterinarians highlight how consistent dosing influences outcomes. Fluctuations in raw herbal preparations introduce uncertainty, an experience we see firsthand during feedback reviews with feed millers and veterinary consultants. Manufactured Clinopodii Herba API addresses these challenges by standardizing concentration for repeatable results across wide-scale livestock operations. This standardization has greater importance in high-value breeds and commercial herds where health setbacks influence not only animal welfare but also operational profitability.

    Differentiating our Product from Commodity Offerings

    Direct manufacturing places us in a unique position compared to resellers or bulk traders. Each lot follows a documented lineage from farm to packaging. Our supply chain does not blend unrelated source material, reducing the risk of adulteration—a common concern in herbal APIs. By drawing on decades of veterinary feed additive manufacturing, we implemented high-resolution HPLC fingerprinting and precise loss-on-drying controls before any production batch is cleared for customer order. These steps effectively end the cycle of “grey market” variability still seen in some regions.

    We limit synthetic additives, focusing on purity and robust microbial integrity. Some competing products, especially those moving through multiple distribution layers, introduce broad-spectrum preservatives or mix in inert bulking agents to cut costs, often diminishing the natural bioactivity of the core ingredient. Our product targets single-ingredient purity and transparent labeling, so both formulators and veterinarians know exactly what goes into every ton of feed or batch of tablets.

    Focus on Safety and Compliance from Field to Finished Goods

    Animal health and regulatory compliance drive our manufacturing protocols. For each market we serve, from livestock feed premix to registered veterinary pharmaceuticals, traceable documentation and up-to-date safety dossiers support every delivery. Avoiding mycotoxin and heavy metal contamination, two persistent risks in herbal APIs, shapes each audit of supplier fields and our intake testing regime. Extraction water, process solvents, and even packaging materials meet pre-set standards for animal health use under GMP conditions.

    Our team’s practical lessons in scale-up answer problems not always visible in laboratory trials—for example, how clinopodii herba’s native antioxidants interact with high-energy fat matrices in premix, or how finished powder loss rates differ in humid versus arid climates. These considerations reveal why partnership with a direct manufacturer matters: issues get solved in real time, by those who have hands on the product itself.

    Versatility of Dosage Forms: Supporting Premix, Solutions, Powders, and More

    Veterinary practices vary widely by region, breed, target illness, and delivery preference. Clinopodii Herba APIs bridge these needs by adapting seamlessly to a spectrum of processing technologies. For pelleted feeds, our granulated grades withstand both steam pelleting and post-pellet coating, delivering core actives without breakdown under heat. During our early years supplying compound feed mills, field partners reported better active retention with our multi-layered granule types versus conventional coarse herb powders.

    For soluble forms, clarity and rapid mixing in water or isotonic saline solutions remain consistent through batch after batch. Livestock producers handling large trough doses or mass medication routines value a product that mixes quickly and stays suspended, even in the field’s unpredictable water conditions. With experiences from dairy barns to swine integrators, our batches are tuned for quick dispersibility and optimal flavor-masking, making administration straightforward for both smallholders and industrial scale operations.

    For capsules and oral tablets, the handleability, flow, and minimal dusting reduce mess during encapsulation and form filling. Solutions and suspensions, on the other hand, draw on our control over extract clarity and preservative-minimization, where customers voice great concern about off-flavors or sedimentation.

    Driving Stability—Storing and Handling Clinopodii Herba APIs

    In practice, real-world issues with herbal APIs often trace back to instability under transport and storage. Our line investments in moisture-proof, oxygen-limited packaging counter oxidation and spoilage—critical for plant-based APIs with sensitive flavonoids and glycosides. We worked closely with packaging engineers, fielding test shipments into tropical, arid, and temperate zones, tracking shelf life and active preservation through extended timelines. Veterinary goods distributors in Southeast Asia and southern Europe report fewer returns and off-color batches since this packaging overhaul.

    We also provide targeted batch storage advice: keeping the product cool, dry, and sealed until use provides the best outcome, and marked lot numbers track recalls if new field problems arise. The reality of direct support from our manufacturing side is that unexpected problems receive rapid investigation and correction, built on close communication with animal health providers and after-sales support teams.

    Batch Consistency—Supporting Animal Health Programs on a Large Scale

    Differences between single-batch and continuous manufacturing, often invisible to end users, become visible when reviewing animal performance across entire herds or flocks. With our commitment to continuous run integrity, we guarantee batch-to-batch uniformity critical for veterinary professionals managing whole-farm preventative programs. Regular technical reviews, both in-house and in customer settings, highlight how repeatable concentration and organoleptic properties affect intake compliance, especially in stressed or recovering animals.

    We continuously refine analytical protocols: HPLC detection, UV profiling, long-term accelerated stability testing—all performed on a per-batch basis. As field feedback shapes our priorities, we update specifications, not just to meet market minimums, but to stay ahead of evolving clinical practices and regulatory demands.

    Insights on Model and Specifications

    Different veterinary practices seek grade-specific features based on their animal species, dose form, and distribution model. Our production range covers high-purity extracts for regulated pharmaceutical lines, granular intermediates for premix applications, and finely milled powders for direct tableting or capsule filling. Each grade targets a particular end use, determined not by generic industry norms but by collaborative work with veterinary scientists evaluating clinical requirements and field logistics.

    Veterinary APIs made in direct partnership with practicing clinicians illuminate issues not often discussed by traders: for instance, lower impurity profiles when handling delicate post-surgical animals, or the need for ultra-low endotoxin grades in injectable preparations. We design lot release specs driven by real-world need, which translates as reduced downtime for producers and better animal welfare outcomes, especially in livestock systems where high animal density leaves no room for compromise.

    Long-Term Benefits over Commodity Alternatives

    Many animal health providers have grown frustrated by the continued influx of poorly-controlled, low-grade botanicals that spike in price and drop in quality without warning. Our manufacturer perspective brings us close to these pain points: the value of predictability and visible traceability runs deeper than convenience. It means that field batches deliver the benefits designed in the laboratory, not just in theory but in each barn, hatchery, or veterinary clinic.

    A recurring topic in our technical workshops, both with distributors and end-users, centers on contamination—whether from persistent pesticides, plant pathogens, or cross-mix with unrelated botanicals. Years of raw material audits and supplier education under our QA team’s oversight have shaped a procurement culture where field-level residue testing complements state-of-the-art manufacturing controls. The benefit is a record of clean, compliant shipments and consistent positive feedback from both veterinarians and regulatory inspectors.

    The feedback cycle between manufacturing site, technical sales, and clinical outcomes creates a unique environment where minor formulation tweaks happen with speed and care, helping maintain customer trust and product superiority. For partners operating at the intersection of animal health and food production, such reliability enables comprehensive health management programs and long-term operational planning.

    Navigating Regional, Regulatory, and Clinical Demands

    Working with veterinary APIs at scale highlights both the diversity of practice and the reality of regulatory scrutiny. Projects for export require preparation of comprehensive documentation, from origin certificates to full impurity and stability profiles. This engagement with regulation moves beyond minimum compliance; our intent is to enable seamless, interruption-free supply into both emerging and established markets. Failure to anticipate these realities leads to costly documentation delays or, worse, brand-damaging recalls.

    Our manufacturing facility invests in ongoing assessment of changing veterinary guidelines—whether new antimicrobial limits, environmental controls, or packaging mandates. Clinical research done in cooperation with veterinary schools and agribusiness partners informs not just the starting API concentration, but also creates risk mitigation across transport, storage, and administration.

    Tailored Support for Veterinary Formulators

    One area where direct manufacturers bring measurable value is in technical consultation for product development. Our experience spans support for new line launches—helping adapt granule density for automated pelletizing, fine-tuning solution grades to pass stability tests in harsh climatic regions, and collaborating during clinical rollout of new oral tablet programs.

    Direct line operations at our plant allow for agile lot scale-up, sample preparation, and real-time adjustment based on feedback from veterinary professionals. Customers seeking to switch away from unreliable supply chains benefit from the open flow of technical support and problem-solving found only in close partnership with the actual production site.

    Summary of Value Propositions

    Clinopodii Herba Veterinary Grade API stands apart due to a direct-from-manufacturer approach rooted in transparency, practical experience, and relentless technical improvement. The process moves well beyond commodity mixing: from precise raw material selection through Hi-Res batch control, close monitoring of processing variables, and hands-on technical support after delivery.

    Our aim remains simple: enable veterinarians, formulators, and animal health managers to rely on a plant-based ingredient whose quality and consistency echo throughout the supply chain—from plant selection to animal benefit. This trust, built on direct experience, strict acceptance criteria, and ongoing adaptation, sets the foundation upon which our partnership with the veterinary community continues to grow.

    Top